Buparlisib is a small molecule which can act as a PI3K inhibitor (pan-Class I). It is provided as a powder. This product acts on the following target types: Kinase, Cytoskeleton. This product acts on the following biochemical pathways: AKT, PI3K, Proliferation, DNA synthesis, Cell cycle. This product may be of interest in the following research areas and diseases: Cell migration, Cancer. Please note that our chemical products are for scientific research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
Target
Buparlisib
Conjugation
Unconjugated
Form
Solid
Purity
> 98%
Reconstitution
Soluble in DMSO (up to 15 mg/ml)
Storage
Store desiccated at -20°C. Solutions can be stored at -20°C for up to 1 month.
Shelf Life
Up to 12 months.
Molecular Weight
410.4 g/mol
Molecular Formula
C18H21F3N6O2
Buffer
Not applicable.
CAS Number
944396-07-0
Availability
Shipped within 5-10 working days.
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.